Seeing Is Believing
Currently out of the existing stock ratings of Andrew Cooper, 136 are a BUY (91.28%), 12 are a HOLD (8.05%), 1 are a SELL (0.67%).
Analyst Andrew Cooper, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 54.49% that have a potential upside of 25.01% achieved within 167 days.
Andrew Cooper’s has documented 280 price targets and ratings displayed on 19 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on HAE, Haemonetics at 11-Aug-2025.
Analyst best performing recommendations are on GH (GUARDANT HEALTH).
The best stock recommendation documented was for GH (GUARDANT HEALTH) at 7/31/2025. The price target of $61 was fulfilled within 21 days with a profit of $20.02 (48.85%) receiving and performance score of 23.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$40
$27.03 (208.40%)
$40
3 months 24 days ago
(05-May-2025)
6/9 (66.67%)
$24.83 (163.68%)
205
Hold
$25
$12.03 (92.75%)
$25
3 months 24 days ago
(05-May-2025)
6/9 (66.67%)
$9.83 (64.80%)
165
Buy
$26
$13.03 (100.46%)
$35
4 months 12 days ago
(17-Apr-2025)
7/10 (70%)
$8.38 (47.56%)
264
Hold
$24
$11.03 (85.04%)
$35
7 months 14 days ago
(15-Jan-2025)
2/2 (100%)
$1.3 (5.73%)
26
Buy
$35
$22.03 (169.85%)
$40
9 months 24 days ago
(05-Nov-2024)
2/7 (28.57%)
$12.1 (52.84%)
294
Which stock is Andrew Cooper is most bullish on?
Which stock is Andrew Cooper is most reserved on?
What Year was the first public recommendation made by Andrew Cooper?